Table 3 Primers used to generate JEV mutations

From: The molecular determinants governing the immunogenicity of Japanese encephalitis live attenuated vaccines

Primers

Sequences

Mutations

177-F

5′- CCAATGCTCCTTCGGTAACCCTCAAAC-3′

G to A

177-R

5′- GTTTGAGGGTTACCGAAGGAGCATTGG-3′

C to T

264-F

5′- GAAGGAGGCCTCCATCAGGCGTTG-3′

T to G

264-R

5′- CAACGCCTGATGGAGGCCTCCTTC-3′

A to C

279-F

5′ - GTACTCAAGCTCAGTGAAGTTAACATCAGG-3′

T to A

279-R

5′- CCTGATGTTAACTTCACTGAGCTTGAGTAC-3′

A to T

315-F

5′- GAAAAATCCGGCGGACACTGGTCAC-3′

T to C

315-R

5′- GTGACCAGTGTCCGCCGGATTTTTC-3′

A to G

F

5′- TTGGCGCGCCAATGCAGG C GCCATGAAGTTGTCGAAT-3′, AscI, KasI

A to C silent mutation

R

5′- GGTCCGGACCAGTCTAGTGACAGATCTGACTC-3′, BspEI, BglII

 
  1. Abbreviation: JEV, Japanese encephalitis virus. Bold is the location of the mutation. The underline entities are the restriction enzyme sites.